FND Education Project

REFERENCE · RECOVERY TECHNIQUE

A Prescriber-Led Medication Discussion for Assessed Globus

Most likely fit: Selected people with assessed globus for whom a prescriber judges a medication discussion appropriate. [Adjacent globus trial evidence; benefit for functional dysphagia is not established]

Original-list entry 10: Discuss gut–brain neuromodulator medication for assessed globus. This is one of eleven original entries; it is not a claim of eleven independently proven treatments.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

When a lump sensation keeps intruding, it is reasonable to ask what treatment options exist. Some medicines used for gut–brain symptoms have been studied in globus. That does not mean everyone should try one or that medication makes swallowing safe.

A neuromodulator is a medicine used to influence nervous-system signaling. Some are also used for depression or pain, but the reason for prescribing should be explained in your own case. This page concerns assessed globus, not a pill for choking, food obstruction or every form of dysphagia.

What this can look like

A 2026 systematic review included 29 trials across several functional esophageal disorders. It found some support for globus, but convincing evidence for functional dysphagia was lacking. Those results should not be treated as evidence for FND-specific swallowing treatment or as an individual chance of success.

Ask about the intended symptom target, alternatives, side effects, interactions and a review date. Depending on the drug and person, issues such as dry mouth, sedation, constipation, cardiac risk or withdrawal may matter. There is no dose recommendation or preferred drug in this page.

A starting point to discuss

  1. Bring a current medicine list and tell the prescriber about relevant conditions and previous reactions.
  2. Agree how benefit and adverse effects will be assessed and when to contact the prescriber.
  3. Ask about swallowing the preparation safely; do not start, increase, stop or crush a medicine based on this page.

These are discussion points for an individualized plan, not instructions to test swallowing at home. [1][2][3]

During a difficult meal or flare

Follow your written swallowing plan and stop oral practice if safety becomes uncertain. Do not try a larger sip, harder food or distraction to get through an unsafe swallow. Ask the team how to maintain hydration and nutrition if usual intake is not possible. Coughing, a wet-sounding voice, repeated sticking or increasing difficulty needs review; lack of coughing does not itself prove safety.

Call emergency services for choking with inability to breathe, speak or cough effectively, severe breathing difficulty or sudden neurological symptoms. Inability to swallow saliva or suspected food obstruction needs urgent medical assessment; do not try to force it down with food or drink. Progressive difficulty, painful swallowing, dehydration, weight loss or recurrent chest infections need prompt review. These safety boundaries concern dysphagia generally, including possible coexisting disease; they do not mean that globus alone is an airway obstruction. 3

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

Support the person in reporting benefit and side effects without treating willingness to take medicine as commitment to recovery. If sedation or another change affects eating, help them contact the care team. Continue the existing swallowing plan.

Use the person’s written flare and emergency plan. If they cannot safely continue eating, do not make the next mouthful a persuasion exercise. Ask for help with ongoing intake and let them recover without repeated tests.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Selection and formulation

Confirm the symptom phenotype and exclude indicated alternatives. Interpret Wang et al. as heterogeneous adjacent evidence: not all 29 trials concern globus, and the review does not establish functional-dysphagia efficacy. Individualize drug choice, contraindications, interaction review, formulation and monitoring. Avoid extrapolating a group response range into a prognosis.

Putting the approach into practice

  1. Document the indication and uncertainty in a shared decision.
  2. Review risks, interactions, oral formulation and monitoring with pharmacy where indicated.
  3. Set a review or stopping strategy and continuing care if medication is ineffective or declined.

The sequence is an educational adaptation for clinical review, not a validated standalone protocol. Agree review thresholds, including a route back to assessment if symptoms change. Preserve appropriate nutrition and hydration support throughout.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

Wang et al. concerns several functional esophageal disorders and is adjacent to this FND collection. It offers some support for globus medication, not convincing evidence for functional dysphagia. Baker et al. provides professional guidance; ASHA supports the general swallowing-safety boundaries. No direct FND-swallowing medication efficacy is claimed.

Citation Full citation
[1] Baker J, Barnett C, Cavalli L, et al. Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy. Journal of Neurology, Neurosurgery & Psychiatry. 2021;92(10):1112–1125. FND-CIT-0025. Source
[2] Wang Z, Zheng Z, Wei X, et al. Efficacy of gut-brain neuromodulators in functional esophageal disorders: a systematic review. BMC Gastroenterology. 2026. FND-CIT-0042. Source
[3] American Speech-Language-Hearing Association. Adult Dysphagia. Practice Portal. Accessed September 18, 2026. FND-CIT-0115. Source

Lived experience: Existing accounts and gaps are recorded in the swallowing source notebook. No new quotation is presented as verified technique evidence.

Source review: September 18, 2026 · Human and clinical review pending.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —